Search

Your search keyword '"Mendes-de-Almeida, Daniela P."' showing total 13 results
Start Over Author "Mendes-de-Almeida, Daniela P." Search Limiters Available in Library Collection
13 results on '"Mendes-de-Almeida, Daniela P."'

1. Vaccine-induced immune thrombotic thrombocytopenia post COVID-19 booster vaccination in Brazil: a case series

Author

Bise Viegas, Anna Paula, Júlio, Liliam Cristiana, Pietrowski Bertuol, Ana Paula, Fernandes, Eder Gatti, Marques de Figueiredo, Risoleide, Ferreira, Rosane, Palm, Cláudia Weingaertner, Burger, Marion, Ferreira, Diogenes Seraphim, Morgenstern, Georgia Karina, Kamoi, Tsukiyo Obu, Mattos de Carvalho, Isis, Jenifer da Silva Araújo Cunha, Juliana, Greffe, Nadja, Nascimento Costa, Nathalya Macedo, Genuino de Souza, Thaina, Lima Frizzera, Renata Loss, Furtado, Barbara Emoingt, Nunes, Gabriele Tantos, Garcez, Tatiana, Filho, Rubens Costa, Rodrigues, Juliana Vassalo, Zago, Luzia, Freire, Claudio Renato, Mendes-de-Almeida, Daniela P., Mouta Nunes de Oliveira, Patrícia, Bertollo Gomes Porto, Victor, Saraiva Pedro, Renata, Takey, Paulo Roberto Gomes, Lignani, Letícia Kegele, Vitiello Teixeira, Gabriellen, Pereira, Tainá dos Santos, Abreu, Debora Lima, Xavier, Janaína Reis, Castro, Thalita da Matta de, Melo de Amorim Filho, Luiz, and Sousa Maia, Maria de Lourdes de

Published
2023
Full Text
View/download PDF

4. A case report of vaccine-induced immune thrombotic thrombocytopenia (VITT) with genetic analysis

Author

Mendes-de-Almeida, Daniela P., primary, Kehdy, Fernanda S. G., additional, Martins-Gonçalves, Remy, additional, Bokel, Joanna, additional, Grinsztejn, Eduarda, additional, Mouta Nunes de Oliveira, Patrícia, additional, Maia, Maria de Lourdes de Sousa, additional, Hoagland, Brenda, additional, Wagner Cardoso, Sandra, additional, Grinsztejn, Beatriz, additional, Siqueira, Marilda M., additional, Kurtz, Pedro, additional, Bozza, Patricia T., additional, and Garcia, Cristiana C., additional

Published
2023
Full Text
View/download PDF

5. Clinical Presentation of Parvovirus B19 Infection in Adults Living with HIV/AIDS: A Case Series

Author

Mendes-de-Almeida, Daniela P., primary, Bokel, Joanna Paes Barreto, additional, Alves, Arthur Daniel Rocha, additional, Vizzoni, Alexandre G., additional, Tavares, Isabel Cristina Ferreira, additional, Silva, Mayara Secco Torres, additional, Netto, Juliana dos Santos Barbosa, additional, Grinsztejn, Beatriz Gilda Jegerhorn, additional, and Amado Leon, Luciane Almeida, additional

Published
2023
Full Text
View/download PDF

7. Evaluation of Anti-PF4 Positivity and Platelet Activation after COVID-19 Vaccination with Ad26.COV2.S in Brazil

Author

Bokel, Joanna, primary, Mendes-de-Almeida, Daniela P., additional, Martins-Gonçalves, Remy, additional, Grinsztejn, Eduarda, additional, Hoagland, Brenda, additional, Wagner, Sandra, additional, Geraldo, Kim Mattos, additional, Coutinho, Sandro Nazer, additional, Georg, Ingebourg, additional, Oliveira de Mello, Maria Helena, additional, Souza, Flávia dos Santos, additional, Vizzoni, Alexandre G., additional, Veloso, Valdiléa, additional, Bozza, Patrícia T., additional, and Grinsztejn, Beatriz, additional

Published
2022
Full Text
View/download PDF

10. Acute promyelocytic leukemia in a long-standing HIV-positive patient: Case report and literature review

Author

Mendes-de-Almeida, Daniela P., Fernandez, Teresa de Souza, Lovatel, Viviane Lamim, da Rocha, Moises Martins, Gomes, Bernadete Evangelho, Monte-Mór, Bárbara C.R., Vianna, Danielle Tavares, Alcoforado, Marília T.G., Kronemberg, João Marcello P.B., Cardoso, João Pedro S.C., Oliveira, Vanessa da Gama, Bokel, Joanna, Vizzoni, Alexandre G., Nunes, Estevão Portela, and Grinsztejn, Beatriz

Published
2022
Full Text
View/download PDF

11. Intracerebral hemorrhage associated with vaccine-induced thrombotic thrombocytopenia following ChAdOx1 nCOVID-19 vaccine in a pregnant woman

Author

Mendes-de-Almeida, Daniela P., primary, Martins-Gonçalves, Remy, additional, Morato-Santos, Renata, additional, De Carvalho, Gustavo Adolpho C., additional, Martins, Silas A., additional, Palhinha, Lohanna, additional, Sandim, Vanessa, additional, Avvad-Portari, Elyzabeth, additional, Bozza, Fernando A., additional, Monteiro, Robson Q., additional, Bozza, Patrícia T., additional, and Kurtz, Pedro, additional

Published
2021
Full Text
View/download PDF

13. Vaccine-induced immune thrombotic thrombocytopenia post COVID-19 booster vaccination in Brazil: a case series.

Author

Mendes-de-Almeida DP, Mouta Nunes de Oliveira P, Bertollo Gomes Porto V, Saraiva Pedro R, Takey PRG, Lignani LK, Vitiello Teixeira G, Pereira TDS, Abreu DL, Xavier JR, Castro TDM, Melo de Amorim Filho L, and Sousa Maia ML

Abstract

Background: The emergence of new variants of SARS-CoV-2 has led to the administration of different booster vaccines to mitigate COVID-19. Vaccines with adenoviral vectors have been rarely associated with vaccine-induced immune thrombotic thrombocytopenia (VITT)., Objectives: This study aimed to describe 15 cases of VITT after the third and fourth doses of the COVID-19 vaccine in Brazil., Methods: Cases were reported after all kinds of anti-SARS-CoV-2 booster vaccinations between October 17, 2021, and September 4, 2022., Results: Of the 26 suspected cases, 15 cases of VITT were analyzed. Of these, 10 were classified as definite VITT, 2 as probable, 1 as possible, and 2 as unlikely. The estimated frequency of definite, probable, or possible VITT was 0.33 cases per million. Cases were assigned to ChAdOx1 (13 cases), Ad26.COV2.S (1 case), and BNT162b2 (1 case). None of the patients received an adenoviral vaccine as a primary vaccination. The average age of participants was 34 years, and symptoms usually appeared 8 days after vaccination. Headache was the most common symptom, and cerebral veins were the most affected thrombotic site. The overall mortality risk was 53%. Anti-platelet factor 4 enzyme-linked immunosorbent assay serology was positive in 11 out of 15 patients (73.3%), negative in 2 (13.3%), and missing in 2 (13.3%)., Conclusion: The study confirms that VITT is linked to the first exposure to adenoviral vector vaccines. Since January 2023, Brazil has recommended preferably COVID-19 messenger RNA vaccines for individuals aged 18 to 39 years. We suggest that, in the current disease scenario, COVID-19 adenovirus vaccines should not be the first choice for individuals aged <50 years who have not received a previous dose of this type of vaccine., (© 2023 The Author(s).)

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results